Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to ...

Chai Discovery more than doubled its valuation to $1.3 billion after raising $130 million to advance A.I.-powered drug ...

Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on ...

Discovering effective drug combinations may now be easier thanks to a screening platform made public today by St. Jude ...

Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a ...

Mo Khalil is the Hok Lam and Kathleen Kam Wong Professor of Bioengineering and Professor of Molecular and Cellular Biology at ...

Chai Discovery, an artificial intelligence drug-discovery company backed by Sam Altman’s OpenAI, has secured $130 million ...

A new chemical method that could speed up the creation of medicines, materials and products people rely on every day has been ...

Artificial intelligence is revolutionizing drug discovery and antibody engineering, accelerating the creation of new ...

Medra, a developer of AI-powered lab robots and scientists to advance drug discovery, raises $52M - SiliconANGLE ...

In this GEN webinar, our expert speakers will explore cutting-edge drug discovery techniques for target deconvolution and multiplex target discovery.

Chemotherapy drugs that target cancer cells without damaging normal cells remain one of the key goals of precision medicine ...